Lieske H. Schrijver

Oral contraceptive use and ovarian cancer risk for BRCA1/2 mutation carriers: an international cohort study

Lieske H. Schrijver, Antonis C Antoniou, Håkan Olsson et al. · American Journal of Obstetrics and Gynecology · 2021 · 62 citations · Full text

Medicine, Gynecology, Oncology +17

Oral Contraceptive Use and Breast Cancer Risk: Retrospective and Prospective Analyses From a BRCA1 and BRCA2 Mutation Carrier Cohort Study

Lieske H. Schrijver, Håkan Olsson, Kelly‐Anne Phillips et al. · JNCI Cancer Spectrum · 2018 · 61 citations · Full text

Medicine, Oncology, Preventive Medicine +16

Dietary vitamin A intake below the recommended daily intake during pregnancy and the risk of congenital diaphragmatic hernia in the offspring

Leonardus W.J.E. Beurskens, Lieske H. Schrijver, Dick Tibboel et al. · Birth Defects Research Part A Clinical and Molecular Teratology · 2013 · 41 citations

Agriculture, Nutrition, Nutritional Sciences +9

Ovarian stimulation for IVF and risk of primary breast cancer in BRCA1/2 mutation carriers

I. A. P. Derks-Smeets, Lieske H. Schrijver, Christine de Die‐Smulders et al. · British Journal of Cancer · 2018 · 29 citations · Full text

Medicine, Gynecology, Oncology +15

Do BRCA1/2 mutation carriers have an earlier onset of natural menopause?

Theodora C van Tilborg, Frank J. Broekmans, Anouk Pijpe et al. · Menopause The Journal of The North American Menopause Society · 2016 · 28 citations · Full text

Life Sciences, Genetics, Molecular Genetics +15